Imatinib-resistant lymphoid clone of chronic myelogenous leukemia in blast phase arising from B cell-committed progenitor leukemic stem cells.
Kobayashi
Shinichi
S
Sato
Ken
K
Kobayashi
Ayako
A
Osawa
Yukiko
Y
Nakamura
Yukitsugu
Y
Kimura
Fumihiko
F
D000328:Adult; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000473:pathology; D001549:Benzamides; D001752:Blast Crisis; D002999:Clone Cells; D019008:Drug Resistance, Neoplasm; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000235:genetics / Q000473:pathology*; D008297:Male; D009154:Mutation; D014411:Neoplastic Stem Cells / Q000473:pathology*; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use; D054448:Precursor Cells, B-Lymphoid / Q000473:pathology; D011743:Pyrimidines / Q000494:pharmacology / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate